Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-08-07

FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Solco Healthcare U.S., LLC)

View source ↗

Summary

FDA approved a supplemental application for cyclobenzaprine hydrochloride (Solco Healthcare U.S., LLC) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOBENZAPRINE HYDROCHLORIDE (Cyclobenzaprine hydrochloride)

Snippet

SUPPL AP for CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE)